Evidence map›Paper›PMID 33563838›Full record

ArticlemBio2021

Intracellular Group A

Takashi Nozawa, Junpei Iibushi, Hirotaka Toh, Atsuko Minowa-Nozawa, Kazunori Murase, Chihiro Aikawa, Ichiro Nakagawa

Open access · goldAbstract read
In one paragraph

Article in mBio, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. The burden of group AiScience · 2025
    Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Interplay between group AMicrobiology and molecular biology reviews : MMBR · 2024
    Review
  15. Article
  16. Vaccines · 2023
    Review
  17. Article
  18. Review
  19. Role of serotype and virulence determinants ofFrontiers in cellular and infection microbiology · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Takashi Nozawa *Department of Microbiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Junpei Iibushi *Department of Microbiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Hirotaka TohDepartment of Microbiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Atsuko Minowa-NozawaDepartment of Microbiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Kazunori MuraseDepartment of Microbiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID 0000-0002-7202-4357
Chihiro AikawaDepartment of Microbiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Ichiro NakagawaDepartment of Microbiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan nakagawa.ichiro.7r@kyoto-u.ac.jp.ORCID 0000-0001-6552-1702
Kyoto University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Group A

Indexed as

A549 CellsBacterial ProteinsCytoplasmEpithelial CellsGolgi ApparatusHeLa CellsHost-Pathogen InteractionsHumansInterleukin-8NAD+ NucleosidaseStreptococcal InfectionsStreptococcus pyogenesStreptolysinsTHP-1 CellsVirulence FactorsBacterial ProteinsInterleukin-8NAD+ Nucleosidasestreptolysin OStreptolysinsVirulence FactorsGolgi apparatusgroup A StreptococcusIL-8NAD-glycohydrolasestreptolysin O

Identifiers

PMID33563838
PMCPMC7885101
OpenAlexW3126938329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.